Oxurion NV to Provide Business and Clinical Update at Upcoming American Academy of Ophthalmology annual meeting (AAO) and Ophthalmology Innovation Summit (OIS @AAO) in San Francisco
(WorldNews Belgium)

Leuven, Belgium , 9 October 2019 - 7.30 AM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diabetic eye disease, today announces that the Company will be providing a business and clinical update at upcoming American Academy of Ophthalmology`s annual meeting (AAO)...